118 related articles for article (PubMed ID: 23244387)
1. Romidepsin and interferon gamma: a novel combination for refractory cutaneous T-cell lymphoma.
Samimi S; Morrissey K; Anshelevich S; Evans K; Gardner J; Musiek A; Vittorio C; Rook A; Kim E
J Am Acad Dermatol; 2013 Jan; 68(1):e5-6. PubMed ID: 23244387
[No Abstract] [Full Text] [Related]
2. Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma.
Whittaker SJ; Demierre MF; Kim EJ; Rook AH; Lerner A; Duvic M; Scarisbrick J; Reddy S; Robak T; Becker JC; Samtsov A; McCulloch W; Kim YH
J Clin Oncol; 2010 Oct; 28(29):4485-91. PubMed ID: 20697094
[TBL] [Abstract][Full Text] [Related]
3. Romidepsin (Istodax) for cutaneous T-cell lymphoma.
Med Lett Drugs Ther; 2010 May; 52(1339):42-3. PubMed ID: 20508581
[No Abstract] [Full Text] [Related]
4. Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma.
Cortes JR; Patrone CC; Quinn SA; Gu Y; Sanchez-Martin M; Mackey A; Cooke AJ; Shih BB; Laurent AP; Trager MH; Ferrando AA; Geskin LJ; Palomero T
J Invest Dermatol; 2021 Dec; 141(12):2908-2920.e7. PubMed ID: 34089720
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous T cell lymphoma of the hand.
Medvedofsky D; Mekori YA; Mor A
Isr Med Assoc J; 2008 Nov; 10(11):827-8. PubMed ID: 19070298
[No Abstract] [Full Text] [Related]
6. Romidepsin: a guide to its clinical use in cutaneous T-cell lymphoma.
Lyseng-Williamson KA; Yang LP
Am J Clin Dermatol; 2012 Feb; 13(1):67-71. PubMed ID: 22066664
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Epstein-Barr virus-associated peripheral T-cell lymphoma.
Imashuku S; Teramura T; Konishi K; Kikuchi A; Tamura S; Maeda Y; Kuroda H
Br J Dermatol; 2004 May; 150(5):1038-40. PubMed ID: 15149529
[No Abstract] [Full Text] [Related]
8. Novel therapeutic combination demonstrates more than additive effects in cutaneous T-cell lymphoma.
Dulmage BO; Story SK; Falo LD; Geskin LJ
Leuk Lymphoma; 2015 Jul; 56(7):2225-7. PubMed ID: 25511681
[No Abstract] [Full Text] [Related]
9. Primary cutaneous blastic natural killer-cell lymphoma.
Conde-Taboada A; De La Torre C; Alcázar JJ; Dios A; Flórez A; Rosón E; Cruces M
Acta Derm Venereol; 2006; 86(3):269-70. PubMed ID: 16710598
[No Abstract] [Full Text] [Related]
10. [Analytical study of 13 cases of cutaneous lymphoma].
Kort R; Mokni M; Rouatbi M; Azaiz MI; Kchir N; Haouet S; Boubaker S; Zitouna M; Ben Osman A
Tunis Med; 1995; 73(6-7):247-52. PubMed ID: 9506173
[No Abstract] [Full Text] [Related]
11. Extracutaneous tumour mass following bexarotene and interferon therapy of primary cutaneous CD30+ large cell lymphoma.
Kreuter A; Altmeyer P; Gambichler T
Acta Derm Venereol; 2006; 86(3):274-5. PubMed ID: 16710601
[No Abstract] [Full Text] [Related]
12. An acute onset of plaques and tumours on the trunk and limbs of a 52-year-old man.
Asher RG; Calonje E; Robson A; Scarisbrick J
Clin Exp Dermatol; 2009 Aug; 34(6):741-2. PubMed ID: 19635117
[No Abstract] [Full Text] [Related]
13. Lax skin masses in a 47-year-old woman.
Herreros FO; Cintra ML; Macedo de Souza E; Velho PE
Arch Dermatol; 2005 Dec; 141(12):1595-600. PubMed ID: 16365268
[No Abstract] [Full Text] [Related]
14. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
[No Abstract] [Full Text] [Related]
15. Romidepsin: a histone deacetylase inhibitor for refractory cutaneous T-cell lymphoma.
Kim M; Thompson LA; Wenger SD; O'Bryant CL
Ann Pharmacother; 2012 Oct; 46(10):1340-8. PubMed ID: 22968522
[TBL] [Abstract][Full Text] [Related]
16. Relief of intractable pruritus with romidepsin in patients with cutaneous T-cell lymphoma: A series of four cases.
Poligone B; Rubio-Gonzalez B; Querfeld C
Dermatol Ther; 2019 Mar; 32(2):e12804. PubMed ID: 30549384
[TBL] [Abstract][Full Text] [Related]
17. Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: single-agent and combination studies.
Foss FM
Semin Oncol; 2000 Apr; 27(2 Suppl 5):58-63. PubMed ID: 10877054
[TBL] [Abstract][Full Text] [Related]
18. Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma.
Nakahashi H; Tsukamoto N; Yamane A; Saitoh T; Uchiumi H; Handa H; Karasawa M; Murakami H; Kojima M; Nojima Y
Acta Haematol; 2009; 121(4):239-42. PubMed ID: 19556752
[No Abstract] [Full Text] [Related]
19. Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy.
Duvic M; Bates SE; Piekarz R; Eisch R; Kim YH; Lerner A; Robak T; Samtsov A; Becker JC; McCulloch W; Waksman J; Whittaker S
Leuk Lymphoma; 2018 Apr; 59(4):880-887. PubMed ID: 28853310
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic use of mistletoe for CD30+ cutaneous lymphoproliferative disorder/lymphomatoid papulosis.
Seifert G; Tautz C; Seeger K; Henze G; Laengler A
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):558-60. PubMed ID: 17374000
[No Abstract] [Full Text] [Related]
[Next] [New Search]
